ID

28322

Descrição

A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin; ODM derived from: https://clinicaltrials.gov/show/NCT01077739

Link

https://clinicaltrials.gov/show/NCT01077739

Palavras-chave

Versões (1)
  1. 04/01/2018 04/01/2018 -
Titular dos direitos

See clinicaltrials.gov

Transferido a

4 de janeiro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Colorectal Cancer NCT01077739

Inglês

Eligibility Colorectal Cancer NCT01077739

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients >/=18 years of age
Descrição

Adult | Age

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
metastatic colorectal cancer
Descrição

Colorectal cancer metastatic

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0948380
at least 1 measurable lesion according to recist v. 1.1
Descrição

Measurable lesion Quantity

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C1265611
patients with disease progression with prior folfiri + avastin therapy who are not candidates for primary metastasectomy
Descrição

Disease Progression | FOLFIRI Regimen | Avastin | Absence Schedule Metastasectomy Primary

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2]
C1880658
UMLS CUI [3]
C1135130
UMLS CUI [4,1]
C0332197
UMLS CUI [4,2]
C0030703
UMLS CUI [4,3]
C2363923
UMLS CUI [4,4]
C0205225
disease progression </= 8 weeks after last dose of avastin
Descrição

Disease Progression

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0242656
ecog </=2
Descrição

ECOG performance status

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1520224
no more than 8 weeks between 1st-line treatment with folfiri + avastin and 2nd-line treatment with xelox or folfox + avastin
Descrição

First line treatment | FOLFIRI Regimen | Avastin | Second line treatment | XELOX | FOLFOX Regimen

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1708063
UMLS CUI [2]
C1880658
UMLS CUI [3]
C1135130
UMLS CUI [4]
C1710038
UMLS CUI [5]
C1956962
UMLS CUI [6]
C0392943
Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
disease progression > 8 weeks after last avastin administration
Descrição

Disease Progression | Status post Avastin

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0242656
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C1135130
clinically significant cardiovascular disease
Descrição

Cardiovascular Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007222
cns disease except for treated brain metastasis
Descrição

CNS disorder | Exception Metastatic malignant neoplasm to brain Treated

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0007682
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0220650
UMLS CUI [2,3]
C1522326
history of other malignancies within 2 years prior to start of study treatment (with the exception of curatively treated basal and squamous cell carcinoma of the skin or in situ carcinoma of the cervix)
Descrição

Cancer Other | Exception Curative treatment Basal cell carcinoma | Exception Curative treatment Squamous cell carcinoma of skin | Exception Curative treatment Carcinoma in situ of uterine cervix

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C1273390
UMLS CUI [2,3]
C0007117
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1273390
UMLS CUI [3,3]
C0553723
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C1273390
UMLS CUI [4,3]
C0851140
major surgery, open biopsy, or significant traumatic injury within 28 days prior to start of study treatment
Descrição

Major surgery | Incisional biopsy | Traumatic injury

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2]
C0184922
UMLS CUI [3]
C3263723
Voltar ao início da página

Similar models

Eligibility Colorectal Cancer NCT01077739

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients >/=18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Colorectal cancer metastatic
Item
metastatic colorectal cancer
boolean
C0948380 (UMLS CUI [1])
Measurable lesion Quantity
Item
at least 1 measurable lesion according to recist v. 1.1
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
Disease Progression | FOLFIRI Regimen | Avastin | Absence Schedule Metastasectomy Primary
Item
patients with disease progression with prior folfiri + avastin therapy who are not candidates for primary metastasectomy
boolean
C0242656 (UMLS CUI [1])
C1880658 (UMLS CUI [2])
C1135130 (UMLS CUI [3])
C0332197 (UMLS CUI [4,1])
C0030703 (UMLS CUI [4,2])
C2363923 (UMLS CUI [4,3])
C0205225 (UMLS CUI [4,4])
Disease Progression
Item
disease progression </= 8 weeks after last dose of avastin
boolean
C0242656 (UMLS CUI [1])
ECOG performance status
Item
ecog </=2
boolean
C1520224 (UMLS CUI [1])
First line treatment | FOLFIRI Regimen | Avastin | Second line treatment | XELOX | FOLFOX Regimen
Item
no more than 8 weeks between 1st-line treatment with folfiri + avastin and 2nd-line treatment with xelox or folfox + avastin
boolean
C1708063 (UMLS CUI [1])
C1880658 (UMLS CUI [2])
C1135130 (UMLS CUI [3])
C1710038 (UMLS CUI [4])
C1956962 (UMLS CUI [5])
C0392943 (UMLS CUI [6])
Item Group
C0680251 (UMLS CUI)
Disease Progression | Status post Avastin
Item
disease progression > 8 weeks after last avastin administration
boolean
C0242656 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C1135130 (UMLS CUI [2,2])
Cardiovascular Disease
Item
clinically significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
CNS disorder | Exception Metastatic malignant neoplasm to brain Treated
Item
cns disease except for treated brain metastasis
boolean
C0007682 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0220650 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
Cancer Other | Exception Curative treatment Basal cell carcinoma | Exception Curative treatment Squamous cell carcinoma of skin | Exception Curative treatment Carcinoma in situ of uterine cervix
Item
history of other malignancies within 2 years prior to start of study treatment (with the exception of curatively treated basal and squamous cell carcinoma of the skin or in situ carcinoma of the cervix)
boolean
C1707251 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1273390 (UMLS CUI [2,2])
C0007117 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C1273390 (UMLS CUI [3,2])
C0553723 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C1273390 (UMLS CUI [4,2])
C0851140 (UMLS CUI [4,3])
Major surgery | Incisional biopsy | Traumatic injury
Item
major surgery, open biopsy, or significant traumatic injury within 28 days prior to start of study treatment
boolean
C0679637 (UMLS CUI [1])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial